Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy

European Journal of Cancer Prevention

Volumn 11, Issue 5, 2002, Pages 473-479

  Apolone, G ^a   Cattaneo, A ^a   Colombo, P ^a   La Vecchia, C ^a   Cavazzuti, L ^a   Bamfi, F ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Benign prostatic hyperplasia; Epidemiology; I PSS; LUTS; Survey

Indexed keywords

ADULT; AGING; ARTICLE; DISEASE SEVERITY; HEALTH STATUS; HEALTH SURVEY; HUMAN; ITALY; MALE; MORBIDITY; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SELF REPORT; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; HUMANS; ITALY; KNOWLEDGE; MALE; MIDDLE AGED; PERSONAL SATISFACTION; PREVALENCE; PROSTATIC DISEASES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; UROLOGIC DISEASES;

EID: 0036803053     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200210000-00010     Document Type: Article

References (21)

1. Abrams P (1994). New words for old: Lower urinary tract symptoms for 'prostatism'. BMJ 308: 929-30.
2. Apolone G, Mosconi P (1998). The Italian SF-36 Health Survey: Translation validation and norming. J Clin Epidemiol 51: 1025- 36.
3. Barry MJ, Fowler FJ JR, O'Leary M, et al. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148: 1549-57.
4. Barry MJ, Fowler FJ, Chang Y, et al. (1995). The American Urological Association symptom index: Does mode of administration affect its psychometric properties?. J Urol 154: 1056.
5. Bland JM, Altman DG (1997). Cronbach's alpha. BMJ 314: 572.
6. Blanker MH, Groeneveld FP, Prins A, et al. (2000). Strong effects of definition and nonreponse bias on prevalence rates of clinical benign prostatic hyperplasia: The Krimpen study of male urogenital tract problems and general health status. Br J Urol Int 85: 665-71.
7. Boyle P (1992). Knowledge and Attitude of Males in France, Italy, the United Kingdom, and West Germany Toward Prostate Disease and Treatment. A Slide Lecture Kit. Merck & Co Inc.
8. Boyle P, McGinn R, Maisonneuve P, et al. (1991). Epidemiology of benign prostatic hyperplasia: Present knowledge and studies needed. Eur Urol 20: 3-10.
9. Boyle P, Keech M, Nonis A, et al. (1998). The UrEpiK Study: A cross-sectional survey of benign prostatic hyperplasia, urinary incontinence and male erectile dysfunction, prostatitis and interstitial cystitis in the UK, France, the Netherlands and Korea. J Epidemiol Biostat 3: 179-87.
10. Clifford GM, Farmer RDT (2000). Medical therapy for benign prostatic hyperplasia: A review of the literature. Eur Urol 38: 2-19.
11. Girman CJ (1998). Population-based studies of the epidemiology of benign prostatic hyperplasia. Br J Urol 82: 34-43.
12. Girman CJ, Jacobsen SJ, Tsukamoto T, et al. (1998). Health- related quality of life associated with lower urinary tract symptoms in four countries. Urology 51: 428-36.
13. Hosmer DW Jr, Lemeshow S (1989). Applied Logistic Regression. John Wiley & Sons, New York.
14. Kleinbaum DG, Kupper LL, Muller KE (1988). Applied Regression Analysis and Other Multivariable Methods. PWS-Kent, Boston.
15. McCredie MRE, Staples M, Johnson W, et al. (2001). Prevalence of urinary symptoms in urban Australian men aged 40-69. J Epidemiol Biostat 6: 211-18.
16. Nunnally JC (1978). Psychometric Theory, 2nd Edn. McGraw Hill, New York.
17. Oishi K, Boyle P, Barry MJ, et al. (1998). Epidemiology and natural history of BPH. In: Proceedings of Fourth International Consultation on Benign Prostatic Hyperplasia (eds Denis LJ, Murphy G, Khoury S); SCI, Jersey.
18. Sagnier PP, Girman CJ, Garraway M, et al. (1996). International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 29: 15-20.
19. Stoevelaar HJ, McDonnell J (2001). Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations. Pharmacoeconomics 19: 131-53.
20. Ware JE, Snow KK, Kosinski M, et al. (1993). SF-36 Health Survey. Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA.
21. Welch G, Kawachi I, Barry MJ, et al. (1998). Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: Findings from the health professionals follow-up study. Urology 51: 422-7.